Bacteria-derived particles as adjuvants for non-replicating nasal vaccines

This publication has 13 references indexed in Scilit:

• Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues
  The Journal of Immunology, 2000
• Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine
  Vaccine, 2000
• A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers
  Journal of Medical Microbiology, 2000
• Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
  Immunology Today, 1999
• Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers
  Vaccine, 1999
• Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice
  Vaccine, 1999
• A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin
  Vaccine, 1997
• Epithelial M Cells: Gateways for Mucosal Infection and Immunization
  Cell, 1996
• Immune response and protection against influenza A infection in mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine
  Vaccine, 1995
• Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.
  Proceedings of the National Academy of Sciences, 1994